Singapore, Aug. 12 -- China-based Fosun Pharma has signed a license agreement with Expedition Therapeutics Inc.to grant the rights to develop, manufacture, and commercialise XH-S004, an orally adminis... Read More
Singapore, Aug. 12 -- Thermo Fisher Scientific, the world leader in serving science, has received approval from the US Food and Drug Administration (FDA) for its Oncomine Dx Target Test as a companion... Read More
Singapore, Aug. 12 -- South Korea based Biostar Stem Cell Technology Research Institute, led by Director Jeong Chan Ra, and jointly operated by R BIO and Nature Cell, has announced that its regenerati... Read More
Singapore, Aug. 12 -- Japan-based Solasia Pharma has entered into a licensing agreement with Firebird Biologics (headquartered in Singapore) granting exclusive rights for the sales and distribution of... Read More
Singapore, Aug. 11 -- France headquartered Sartorius Stedim Biotech, a leading partner to the biopharmaceutical industry, and US-based startup Nanotein Technologies, a developer of next-generation imm... Read More
Singapore, Aug. 11 -- South Korea-based Hugel Inc., a leading global medical aesthetics company, has officially launched its botulinum toxin product Letybo inMalaysia- an emerging market for medical a... Read More
Singapore, Aug. 11 -- Shimadzu will launch aparticle analysis systemin Japan and overseas, specialising in the analysis of microplastics, at global scale. This system can quickly calculate the number ... Read More
Singapore, Aug. 11 -- Codex Genetics, one of the leading precision diagnostics companies in Hong Kong, has announced an exclusive collaboration with New Zealand-basedPacific Edge, the developer of the... Read More
Singapore, Aug. 9 -- The Ministry of Health and Prevention(MoHAP) in the UAE has signed a Memorandum of Understanding (MoU) with Sanofi, to promote healthy lifestyles, advance early detection of nonco... Read More
Singapore, Aug. 9 -- South Korea-based Celltrion, Inc. has announced that the US Food and Drug Administration (FDA) has approved an expanded indication of the intravenous (IV) formulation of AVTOZMA(R... Read More